Two Sigma Advisers’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-47,200
| Closed | -$2.12M | – | 2401 |
|
|
2023
Q1 | $2.12M | Sell |
47,200
-28,700
| -38% | -$1.29M | 0.01% | 1247 |
|
|
2022
Q4 | $3.33M | Buy |
75,900
+14,000
| +23% | +$613K | 0.01% | 956 |
|
|
2022
Q3 | $4.08M | Buy |
+61,900
| New | +$4.08M | 0.01% | 836 |
|
|
2020
Q1 | – | Sell |
-73,600
| Closed | -$5.9M | – | 2466 |
|
|
2019
Q4 | $5.9M | Sell |
73,600
-43,500
| -37% | -$3.48M | 0.01% | 787 |
|
|
2019
Q3 | $8.6M | Buy |
117,100
+2,900
| +3% | +$213K | 0.02% | 593 |
|
|
2019
Q2 | $10.8M | Sell |
114,200
-2,200
| -2% | -$208K | 0.03% | 562 |
|
|
2019
Q1 | $9.32M | Sell |
116,400
-42,900
| -27% | -$3.43M | 0.02% | 629 |
|
|
2018
Q4 | $8.59M | Sell |
159,300
-2,300
| -1% | -$124K | 0.02% | 611 |
|
|
2018
Q3 | $12.6M | Sell |
161,600
-65,400
| -29% | -$5.1M | 0.03% | 517 |
|
|
2018
Q2 | $14.4M | Buy |
227,000
+151,800
| +202% | +$9.64M | 0.04% | 474 |
|
|
2018
Q1 | $6.9M | Sell |
75,200
-6,200
| -8% | -$569K | 0.02% | 725 |
|
|
2017
Q4 | $6.14M | Buy |
81,400
+38,400
| +89% | +$2.9M | 0.02% | 780 |
|
|
2017
Q3 | $3M | Buy |
43,000
+33,100
| +334% | +$2.31M | 0.01% | 1014 |
|
|
2017
Q2 | $502K | Sell |
9,900
-1,500
| -13% | -$76.1K | ﹤0.01% | 1799 |
|
|
2017
Q1 | $456K | Buy |
+11,400
| New | +$456K | ﹤0.01% | 1933 |
|